HOME >> BIOLOGY >> NEWS
Potential allergy vaccine boosts hope for sufferers

Australian scientists have developed a potential vaccine for hayfever and other pollen related allergies.

The breakthrough could provide a lifeline to the 25 percent of the world's population suffering severe allergic responses to pollen.

Working with a rye grass protein - one of the most potent environmental allergens known - the team, from the University of Melbourne's Plant Molecular Biology and Biotechnology Group, has modified the gene responsible for its production.

The modified gene produced a protein that has a significantly reduced allergenic response, yet one still capable of boosting a person's immune response. These twin features are the key to a potential vaccine, or effective immunotherapy - the practice of giving allergic patients small, but increasing doses of allergen-containing extracts to boost their immunity to the allergen.

"Skin prick tests to assess the protein's safety suggest it is a significantly safer and more effective alternative to the current immunotherapy used to treat grass pollen allergies," says Associate Professor Prem Bhalla, joint leader of the group.

Their research is published in the latest European Journal of Immunology.

Current immunotherapy carries a significant risk of lethal side effects that include anaphylactic shock, a condition where the body rapidly becomes hypersensitive to an allergen.

"The symptoms of allergenic disease, like asthma, hayfever, allergic dermatitis and conjunctivitis, can be controlled with drugs, but specific immunotherapy is the only way to treat the causes of allergies that produce a potentially life threatening hypersensitivity (Type 1 allergies), says Bhalla.

Since its introduction in 1911, immunotherapy therapy has been subject to criticism and debate largely because the underlying immunological mechanisms of the human body are still unknown and because there has been no way of controlling the contents of the allergen-containing
'"/>

Contact: Jason Major
jmajor@unimelb.edu.au
61-3-8344-0181
University of Melbourne
6-Feb-2002


Page: 1 2 3

Related biology news :

1. Potential for enhanced sequestration of carbon in soils supports evaluations
2. Potential blood test for colon cancer risk
3. Potential new treatment for Gaucher disease developed by scientists at Scripps Research Institute
4. Potential cause of arthritis discovered
5. Potential of regenerative medicine explored
6. Potential therapy reported for children, adults with end-stage liver disease
7. Potential of tailoring drugs to genetic makeup confirmed--but challenges remain
8. Potential new anthrax therapy discovered
9. Potential gene therapy carriers created that mimic viruses, without the risk
10. New Class Of Synthetic Capsules That Mimic Biological Cells Has Wide Array Of Potential Uses
11. Role Of Protein Linked To Colon Cancer Identified, Offering Potential Target For Therapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/19/2020)... FARMINGTON, Conn. (PRWEB) , ... March 17, 2020 ... ... that develops tools for characterizing microbiome populations down to the strain level, recently ... , The Shoreline Wave amplicon kit contains the same innovative amplification capabilities as ...
(Date:3/13/2020)... ... March 13, 2020 , ... Acumed LLC today announced that ... distributor of the Louisville-based company’s orthobiologics portfolio. Under the terms of the agreement, ... calcium phosphate-based bone allograft (Trabexus) and calcium phosphate-based biocement (Fortera). Vivorte will continue ...
(Date:3/9/2020)... ... March 09, 2020 , ... ... steep growth rate of 64% last year, as enterprises sought to achieve ... Everest Group. Unfortunately, only 13% of all transformation efforts delivered the intended ...
Breaking Biology News(10 mins):
(Date:2/19/2020)... (PRWEB) , ... February 19, 2020 , ... ... process solutions for the life sciences industry, today announced the opening of a ... Nagamura, Associate Partner, Red Nucleus R&D. , Red Nucleus announced the new office ...
(Date:2/10/2020)... ... February 10, 2020 , ... R3 Medical Training announced it is now registering ... Las Vegas. The course is hands on involving real patients and stem cell biologics, ... the Comprehensive Stem Cell Training Course has received rave reviews from attendees, who love ...
(Date:2/3/2020)... Mass. (PRWEB) , ... February 03, 2020 , ... ... US offices in Cambridge, MA, announce that OmniType, the 11-locus, single tube multiplex ... today. OmniType is a best-in-class product featuring locus-multiplexing and short library preparation, for ...
(Date:1/27/2020)... ... January 27, 2020 , ... Cerebyte, the leader in ... computing, today announced the availability of neuroscience of transformational leadership workshops. These highly ... neuroscience of leadership and change research to become great transformational leaders. The ...
Breaking Biology Technology:
Cached News: